Press release: New live attenuated TB vaccine is safe and shows a distinct, dose dependent immune response in a Phase1b trial in newborns
The initial results of the Phase 1b study have been presented at the 5th Global Forum on TB vaccines in Delhi. Please read the press release.
A new TB vaccine is an inevitability; the question is how long will it take us to get there? Please read the article about progress and challenges in TB vaccine development.